Portfolio Companies News
August 10, 2020Orexo receives paragraph IV Notice ...
Uppsala, Sweden – August 10, 2020 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces it has received a “paragraph IV” patent certification notice from Sun Pharmaceutical Industries Limited (“Sun”). The Notice Letter advises Orexo of Sun’s filing of an Abbreviated New Drug ... read more
August 10, 2020Nordic Nanovector Appoints Dr Chris...
Oslo, Norway, 10 August 2020 Nordic Nanovector ASA (OSE: NANO) announces that Dr Christine Wilkinson Blanc has been appointed Chief Medical Officer with immediate effect. Dr Wilkinson Blanc is a seasoned pharmaceutical physician with broad experience in oncology and haematology with bot... read more
August 7, 2020Oncopeptides initiates the first st...
STOCKHOLM — August 7, 2020 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) announced today that the first patient has been enrolled in the Immunoglobulin Light Chain (AL) amyloidosis (OP-201) study. This open-label, phase 1/2 study of melflufen and dexamethasone for patients with AL ... read more
August 6, 2020Independent Review Committee Recomm...
Oslo, Norway, 6 August 2020 Nordic Nanovector ASA (OSE: NANO) today announces that, following a planned interim analysis of the PARADIGME Phase 2b pivotal trial of Betalutin® in patients with relapsed/refractory follicular lymphoma (FL), the Independent Review Committee (IRC) has reco... read more
August 5, 2020Fusion Pharmaceuticals To Present A...
HAMILTON, Ontario and BOSTON, Aug. 5, 2020 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that Chief Executive Officer John Valliant, Ph.D., will... read more
August 05, 2020Q2 2020 General Market Overview
Since the start in 1996, HealthCap funds have invested in 115 portfolio companies.
44 of the portfolio companies have been taken public on nine different markets.
26 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.